Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Monmouth Junction, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
Ayala Pharmaceuticals, Inc. has filed 1,330 SEC EDGAR filings since 14 Dec 1999

SEC filing history

Showing 401-425 of 1,000 matching filings.

Per page
25
Current page
17
SC 13G/A File 005-80101

ADVAXIS, INC.

Filing date
27 Sep 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

ADAGE CAPITAL PARTNERS, GP L.L.C.

Filing date
26 Sep 2017
Reporting date
22 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36138

8-K filing

Filing date
25 Sep 2017
Reporting date
25 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-36138

10-Q filing

Filing date
11 Sep 2017
Reporting date
31 Jul 2017
Next action
Verify source filing
8-K File 001-36138

8-K filing

Filing date
11 Sep 2017
Reporting date
11 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Sep 2017
Reporting date
31 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Sep 2017
Reporting date
31 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 Aug 2017
Reporting date
31 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 Aug 2017
Reporting date
31 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36138

8-K filing

Filing date
21 Jul 2017
Reporting date
18 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
12 Jul 2017
Reporting date
06 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36138

8-K filing

Filing date
07 Jul 2017
Reporting date
06 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Jul 2017
Reporting date
30 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Jul 2017
Reporting date
30 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Jul 2017
Reporting date
30 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 Jun 2017
Reporting date
19 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 Jun 2017
Reporting date
19 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 Jun 2017
Reporting date
19 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-36138

10-Q filing

Filing date
06 Jun 2017
Reporting date
30 Apr 2017
Next action
Verify source filing
4

4 filing

Filing date
01 Jun 2017
Reporting date
31 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 Jun 2017
Reporting date
31 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 Jun 2017
Reporting date
31 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 May 2017
Reporting date
28 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 May 2017
Reporting date
28 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 May 2017
Reporting date
28 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .